Table 4 Patient evaluations
COM | NT | ||||||
|---|---|---|---|---|---|---|---|
# | % | 95% CIa | # | % | 95% CIa | ||
Symptom relief | Complete resolution* | 30 | 12.9 | 7.8–18.1 | 12 | 7.4 | 3.1–11.7 |
Considerably weaker | 68 | 29.3 | 23.5–35.2 | 64 | 39.5 | 32.9–46.1 | |
Somehow weaker | 63 | 27.2 | 20.8–33.5 | 47 | 29.0 | 22.0–36.0 | |
Unchanged | 61 | 26.3 | 20.7–31.9 | 34 | 21 | 16.2–25.8 | |
Very intense | 9 | 3.9 | 1.4–6.4 | 4 | 2.5 | 0.2–4.7 | |
Unsupportable | 1 | 0.4 | 0–1.3 | 1 | 0.6 | 0–1.8 | |
Fulfillment of treatment expectations* | Proportion of "complete fulfilled" | 33 | 15 | 9.6–20.5 | 40 | 24.8 | 18.5–31.2 |
Overall Satisfaction* | Proportion of "very satisfied" | 66 | 29.5 | 22.7–36.2 | 66 | 41.3 | 35.9–46.6 |
Adverse side effects | Yes | 29 | 12.9 | 8.4–17.5 | 17 | 10.6 | 8.2–12.9 |
Severity of side effects | weak | 4 | 13.8b | 1.6–26.0 | 7 | 41.2 | 13.1–69.2 |
moderate | 18 | 62.1 | 45.2–78.9 | 5 | 29.4 | 6.9–52.0 | |
strong | 7 | 24.1 | 7.6–40.7 | 5 | 29.4 | 7.7–51,2 | |
Other effects* | Positive | 38 | 17.7 | 13.1–22.3 | 59 | 37.6 | 29.1–46.1 |
Negative | 16 | 7.4 | 3.8–11.1 | 9 | 5.7 | 2.5–9.0 | |
No effect | 161 | 74.9 | 70.3–79.5 | 89 | 56.7 | 47.0–66.4 | |
Perceived causality of symptom relief* | Very sure | 59 | 29.7 | 22.2–37.1 | 62 | 44.3 | 36.0–52.6 |
Sure | 77 | 38.7 | 31.0–46.4 | 55 | 39.3 | 29.9–48.7 | |
Not sure | 39 | 19.6 | 13.7–25.5 | 12 | 8.6 | 4.1–13.1 | |
Don't know | 24 | 12.1 | 7.0–17.1 | 11 | 7.9 | 3.1–12.6 | |